日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Establishing a standard surgery for esophagogastric junction cancer: Final results from the JGCA-JES nationwide prospective study

建立食管胃交界处癌的标准手术方案:JGCA-JES 全国前瞻性研究的最终结果

Kurokawa, Yukinori; Takeuchi, Hiroya; Doki, Yuichiro; Mine, Shinji; Terashima, Masanori; Yasuda, Takushi; Yoshida, Kazuhiro; Daiko, Hiroyuki; Sakuramoto, Shinichi; Yoshikawa, Takaki; Kunisaki, Chikara; Seto, Yasuyuki; Tamura, Shigeyuki; Shimokawa, Toshio; Sano, Takeshi; Kitagawa, Yuko

Influence of Hospital and Surgeon Volumes on Clinical Outcomes After Standard Surgery for Advanced Gastric Cancer: Supplementary Analysis of the Multicenter Randomized Phase III Trial JCOG1001

医院和外科医生手术量对晚期胃癌标准手术后临床结果的影响:多中心随机III期试验JCOG1001的补充分析

Hirao, Motohiro; Kurokawa, Yukinori; Kajikawa, Riku; Mizusawa, Junki; Kawabata, Kota; Tokunaga, Masanori; Kuroda, Kenji; Sakuramoto, Shinichi; Yasufuku, Itaru; Matsushita, Hisayuki; Takiguchi, Shuji; Doki, Yuichiro; Yoshikawa, Takaki; Terashima, Masanori

Correction: Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study

更正:PINK1蛋白表达作为结直肠癌辅助化疗疗效预测标志物的评估:一项回顾性研究

Fujii, Takatsugu; Hirasaki, Masataka; Kamakura, Yasuo; Kawasaki, Tomonori; Yamasaki, Satoshi; Ishiyama, Yasuhiro; Hiranuma, Chikashi; Hamaguchi, Tetsuya; Hirano, Yasumitsu; Sakuramoto, Shinichi

Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary

纳武利尤单抗联合化疗治疗亚洲晚期或复发性胃癌或胃食管交界处癌患者(ATTRACTION-4 研究):简明语言摘要

Chen, Li-Tzong; Kang, Yoon-Koo; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Chung, Ik-Joo; Yamaguchi, Kensei; Kato, Ken; Sym, Sun Jin; Kadowaki, Shigenori; Tsuji, Kunihiro; Chen, Jen-Shi; Bai, Li-Yuan; Oh, Sung-Yong; Choda, Yasuhiro; Yasui, Hisateru; Takeuchi, Kentaro; Hirashima, Yoshinori; Hagihara, Shunsuke; Boku, Narikazu

Clinical benefits including the postoperative inflammatory status of robot-assisted distal gastrectomy for gastric cancer compared with laparoscopic distal gastrectomy in patients with obesity

在肥胖患者中,机器人辅助远端胃切除术治疗胃癌的临床获益(包括术后炎症状态)与腹腔镜远端胃切除术相比。

Matsui, Kazuaki; Sakuramoto, Shinichi; Furube, Tasuku; Yoshizawa, Masatoshi; Toriumi, Tetsuro; Ebara, Gen; Miyawaki, Yutaka; Sato, Hiroshi

Clinical advantages of two vs. three courses of neoadjuvant chemotherapy using docetaxel + cisplatin + 5-fluorouracil to improve preoperative nutritional status and mitigate decreasing skeletal muscle in resectable esophageal cancer

对于可切除食管癌患者,采用多西他赛+顺铂+5-氟尿嘧啶进行两疗程新辅助化疗与三疗程新辅助化疗相比,在改善术前营养状况和减轻骨骼肌减少方面具有临床优势

Matsui, Kazuaki; Miyawaki, Yutaka; Kobayashi, Ryota; Yoshizawa, Masatoshi; Toriumi, Tetsuro; Ebara, Gen; Sato, Hiroshi; Sakuramoto, Shinichi

Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study.

PINK1 蛋白表达作为结直肠癌辅助化疗疗效预测标志物的评价:一项回顾性研究

Fujii Takatsugu, Hirasaki Masataka, Kamakura Yasuo, Kawasaki Tomonori, Yamasaki Satoshi, Ishiyama Yasuhiro, Hiranuma Chikashi, Hamaguchi Tetsuya, Hirano Yasumitsu, Sakuramoto Shinichi

Prognostic Impact of Preoperative Left Ventricular Systolic Dysfunction in Older Adult Patients With Gastric Cancer

术前左心室收缩功能障碍对老年胃癌患者预后的影响

Takabatake, Kazuya; Sakuramoto, Shinichi; Kobayashi, Ryota; Toriumi, Tetsuro; Ebara, Gen; Li, Seigi; Miyawaki, Yutaka; Sato, Hiroshi; Yamashita, Keishi

Comparisons in Postoperative Endoscopic Findings and Postoperative Weight Change Between Delta-Shaped Anastomosis and Circular-Stapled Anastomosis in Laparoscopy-Assisted Distal Gastrectomy With B-I Reconstruction

腹腔镜辅助远端胃切除联合肠道重建术中三角吻合与圆形吻合器吻合术后内镜检查结果及术后体重变化比较

Oya, Shuichiro; Sakuramoto, Shinichi; Morimoto, Yosuke; Matsui, Kazuaki; Nishibeppu, Keiji; Ebara, Gen; Fujita, Shohei; Fujihata, Shiro; Lee, Seigi; Miyawaki, Yutaka; Sugita, Hirofumi; Sato, Hiroshi; Yamashita, Keishi

Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial

纳武利尤单抗联合化疗治疗HER2阴性、既往未接受治疗、不可切除、晚期或复发性胃/胃食管交界处癌患者:ATTRACTION-4随机、双盲、安慰剂对照3期试验的3年随访结果

Boku, Narikazu; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Yamaguchi, Kensei; Kato, Ken; Kadowaki, Shigenori; Tsuji, Kunihiro; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Chung, Ik-Joo; Sym, Sun Jin; Chen, Li-Tzong; Chen, Jen-Shi; Bai, Li-Yuan; Nakada, Takashi; Hagihara, Shunsuke; Makino, Reina; Nishiyama, Eiji; Kang, Yoon-Koo